Cite

HARVARD Citation

    Gupta, N. et al. (n.d.). 282PInhibition of miR-144 and miR-199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling. Annals of oncology. p. . [Online]. 
  
Back to record